T. Rowe Price Investment Management
BMY icon

T. Rowe Price Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

T. Rowe Price Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
+19,177
New +$1.12M ﹤0.01% 619
2025
Q3 		– Sell
-3,113
Closed -$145K – 895
2025
Q2 		$145K Buy
+3,113
New +$153K ﹤0.01% 660

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management's BMY Position: Q1 2026 in Review

T. Rowe Price Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 19,177 shares worth $1.16M. The stake represents ﹤0.01% of the portfolio and ranks #619 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in BMY as recently as Q2 2025.

T. Rowe Price Investment Management first reported a position in BMY in Q2 2025 and has held it in 2 quarters since. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • T. Rowe Price Investment Management held 19,177 shares of Bristol-Myers Squibb worth $1.16M as of Q1 2026.
  • Bristol-Myers Squibb was a new T. Rowe Price Investment Management position in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #619 holding.
  • T. Rowe Price Investment Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 2 quarters since.
  • 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.